Impulsive Behavior: Clinical Trials

2 trials for Impulsive Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Unknown 2

Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
Exenatide, Desacyl ghrelin, Saline - Obesity, Smoking Cessation
Early Phase 1UnknownImperial College London952015-08-012020-02-13
Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction
Deep brain stimulation, Placebo - Addiction
Early Phase 1UnknownJens Kuhn102011-01-012016-12-07

Narrower conditions

Behavior, Addictive (2)  ·  Alcoholism (1)  ·  Obesity (1)  ·  Smoking Cessation (1)

Broader conditions

Behavior (2)  ·  Compulsive Behavior (2)  ·  Alcohol-Related Disorders (1)  ·  Body Weight (1)  ·  Chemically-Induced Disorders (1)  ·  Health Behavior (1)  ·  Mental Disorders (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

Deep Brain Stimulation (1)  ·  Exenatide (1)  ·  Sodium Chloride (1)  ·  ghrelin, des-n-octanoyl (1)

Sponsors

Imperial College London (1)  ·  Jens Kuhn (1)

Countries

Germany (1)  ·  United Kingdom (1)

Top investigators

David Nutt, MD, PhD (1)  ·  Jens Kuhn, MD (1)  ·  Tony Goldstone, MD, PhD (1)  ·  Veerle Visser-Vandewalle, MD (1)

Results publications

PMID 26827109